Table 1

Potential predictor variables for survival in patients diagnosed with malignant pleural mesothelioma in Portsmouth, UK

GroupVariable
DemographicsAge at diagnosis
Gender
Clinical examination/medical historyWeight
Body mass index (BMI)
Any known history of asbestos exposure
Smoking status at diagnosis (never smoker, ex-smoker, current smoker)
ECOG performance status (PS) at diagnosis (range 0–4)
Diagnosed respiratory comorbidity
Diagnosed non-respiratory comorbidity
Total no of comorbidities
Symptoms at diagnosisDyspnoea
Chest pain
Cough
Weight loss
Loss of appetite
Night sweats
Fever
PathologyHistological subtype
Cytology—presence of malignant cells
HaematologyHaemoglobin (Hb)
Red cell distribution and width (RDW)
Platelet count (PLT)
Systemic inflammationWhite blood cell count (WCC)
Neutrophil lymphocyte ratio (NLR)
C-Reactive protein (CRP)
Renal functionUrea
Sodium (Na)
Potassium (K)
Creatinine
Liver functionTotal protein
Albumin
Alkaline phosphatase (ALP)
Bone profileAdjusted calcium
Phosphate
Pleural fluid biochemistryTotal protein
Lactate dehydrogenase (LDH)